1. Home
  2. CHR vs FATE Comparison

CHR vs FATE Comparison

Compare CHR & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheer Holding Inc.

CHR

Cheer Holding Inc.

HOLD

Current Price

$1.44

Market Cap

142.9M

Sector

Technology

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.18

Market Cap

139.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHR
FATE
Founded
2016
2007
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.9M
139.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CHR
FATE
Price
$1.44
$1.18
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$3.92
AVG Volume (30 Days)
151.9K
1.8M
Earning Date
07-30-2025
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
96.06
N/A
Revenue
$147,134,000.00
$7,137,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$0.66
52 Week High
$141.71
$1.94

Technical Indicators

Market Signals
Indicator
CHR
FATE
Relative Strength Index (RSI) 52.39 53.37
Support Level $1.48 $1.17
Resistance Level $1.63 $1.32
Average True Range (ATR) 0.15 0.09
MACD -0.08 0.01
Stochastic Oscillator 3.93 51.67

Price Performance

Historical Comparison
CHR
FATE

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: